tiprankstipranks
Advertisement
Advertisement
XVIPF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsXVIPF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
23d ago
XVIVO Sets April 24 Call to Present Q1 2026 Interim Report
Premium
Company Announcements
XVIVO Sets April 24 Call to Present Q1 2026 Interim Report
28d ago
XVIVO’s Heart Preservation Trial Shows Improved One‑Year Outcomes in European Study
Premium
Company Announcements
XVIVO’s Heart Preservation Trial Shows Improved One‑Year Outcomes in European Study
29d ago
XVIVO Elevates CFO to Lead Global Strategy as It Targets U.S. Growth
PremiumCompany AnnouncementsXVIVO Elevates CFO to Lead Global Strategy as It Targets U.S. Growth
3M ago
XVIVO Delays Q1 2026 Report to Spotlight Key U.S. Heart Study
Premium
Company Announcements
XVIVO Delays Q1 2026 Report to Spotlight Key U.S. Heart Study
3M ago
XVIVO Perfusion Balances Organ Business Growth With Heavy R&D Spend in 2025
Premium
Company Announcements
XVIVO Perfusion Balances Organ Business Growth With Heavy R&D Spend in 2025
4M ago
Xvivo Perfusion upgraded to Buy from Hold at Danske Bank
PremiumThe FlyXvivo Perfusion upgraded to Buy from Hold at Danske Bank
7M ago
XVIVO Perfusion AB Reports Mixed Financial Results for 2025
Premium
Company Announcements
XVIVO Perfusion AB Reports Mixed Financial Results for 2025
7M ago
XVIVO Perfusion AB Reports Mixed Financial Results Amid Strategic Investments
Premium
Company Announcements
XVIVO Perfusion AB Reports Mixed Financial Results Amid Strategic Investments
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100